Hawkins (NASDAQ:HWKN – Get Free Report)‘s stock had its “buy” rating reissued by analysts at BWS Financial in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $200.00 price target on the specialty chemicals company’s stock. BWS Financial‘s price objective suggests a potential upside of 30.00% from the stock’s current price.
Several other brokerages also recently weighed in on HWKN. Weiss Ratings upgraded Hawkins from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, September 21st. Zacks Research downgraded Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 4th. Finally, Barclays set a $141.00 target price on Hawkins and gave the company an “equal weight” rating in a research note on Tuesday, October 13th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $170.50.
Read Our Latest Analysis on HWKN
Hawkins Stock Up 13.6%
NASDAQ:HWKN traded up $18.41 during mid-day trading on Tuesday, hitting $153.85. The company had a trading volume of 423,990 shares, compared to its average volume of 164,276. The business has a fifty day simple moving average of $126.44 and a 200-day simple moving average of $143.14. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. Hawkins has a 1 year low of $116.04 and a 1 year high of $174.12. The firm has a market capitalization of $3.21 billion, a price-to-earnings ratio of 39.86, a PEG ratio of 2.71 and a beta of 0.74.
Hawkins (NASDAQ:HWKN – Get Free Report) last announced its earnings results on Monday, October 26th. The specialty chemicals company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.15. The company had revenue of $313.82 million during the quarter, compared to the consensus estimate of $302.70 million. Hawkins had a return on equity of 15.42% and a net margin of 7.29%. Equities analysts forecast that Hawkins will post 4.07 earnings per share for the current fiscal year.
Insider Activity
In other news, CFO Jeffrey P. Oldenkamp acquired 1,290 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was purchased at an average cost of $119.00 per share, with a total value of $153,510.00. Following the completion of the acquisition, the chief financial officer directly owned 104,223 shares in the company, valued at $12,402,537. This represents a 1.25% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Douglas A. Lange acquired 910 shares of the stock in a transaction that occurred on Tuesday, August 25th. The stock was purchased at an average cost of $118.75 per share, with a total value of $108,062.50. Following the completion of the acquisition, the vice president owned 28,169 shares of the company’s stock, valued at $3,345,068.75. The trade was a 3.34% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 3.70% of the stock is owned by company insiders.
Institutional Trading of Hawkins
Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in Hawkins in the second quarter valued at about $449,055,000. Bowen Hanes & Co. Inc. increased its holdings in Hawkins by 4.3% in the first quarter. Bowen Hanes & Co. Inc. now owns 380,520 shares of the specialty chemicals company’s stock valued at $58,448,000 after buying an additional 15,550 shares during the last quarter. First Trust Advisors LP increased its holdings in Hawkins by 1.2% in the first quarter. First Trust Advisors LP now owns 186,761 shares of the specialty chemicals company’s stock valued at $28,686,000 after buying an additional 2,155 shares during the last quarter. William Blair Investment Management LLC bought a new stake in Hawkins in the second quarter valued at about $27,212,000. Finally, London Co. of Virginia bought a new stake in Hawkins in the first quarter valued at about $26,791,000. 69.71% of the stock is owned by institutional investors.
Hawkins News Summary
Here are the key news stories impacting Hawkins this week:
- Positive Sentiment: Earnings and revenue exceeded expectations. Hawkins reported adjusted EPS of $1.34, up from $1.08 a year earlier and above analyst estimates of approximately $1.19–$1.22. Revenue increased 11.9% year over year to $313.8 million, surpassing estimates near $302.7 million. Hawkins fiscal second-quarter results
- Positive Sentiment: Profitability and cash generation improved. Gross profit rose to $76.6 million, operating profit reached $41.9 million, and net income attributable to common shareholders increased to $27.8 million. Operating cash flow was $40.3 million, supporting the market’s positive reaction to the report.
- Positive Sentiment: BWS Financial reaffirmed its “buy” rating and raised or maintained a $200 price target, implying substantial upside from the recent trading level. This reinforces bullish sentiment following the earnings beat. BWS Financial rating
- Positive Sentiment: The quarterly dividend was increased. Hawkins declared a $0.20-per-share dividend payable November 25, representing a 5.3% increase from the prior $0.19 payment and a $0.80 annualized payout. Hawkins dividend announcement
- Neutral Sentiment: Recent filings and market data indicate some insider purchases and mixed institutional positioning. These signals may support confidence but are less significant than the earnings results and analyst target.
Hawkins Company Profile
Hawkins, Inc (NASDAQ:HWKN) is a chemical manufacturer, blender and distributor serving customers across the United States. The company supplies a range of water treatment chemicals, industrial chemicals and specialty products to municipal, commercial and industrial users.
Its water treatment business provides chemicals and related solutions used in drinking water, wastewater and industrial water treatment applications. Hawkins also serves the industrial, health and nutrition, and specialty chemical markets, offering products such as chemical blends, custom formulations and other materials used in manufacturing, agriculture, food processing and pharmaceutical applications.
Founded in 1938, Hawkins is headquartered in Roseville, Minnesota, and operates through a network of manufacturing, blending, distribution and sales locations in the United States.
Featured Articles
- Five stocks we like better than Hawkins
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
